HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hugh G Laverty Selected Research

human TGFB3 protein

9/2011Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring.
9/2010Effects of avotermin (transforming growth factor β3) in a clinically relevant pig model of long, full-thickness incisional wounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hugh G Laverty Research Topics

Disease

2Cicatrix (Scar)
09/2011 - 01/2008
1Drug-Related Side Effects and Adverse Reactions
04/2011
1Fibrosis (Cirrhosis)
10/2010
1Inflammation (Inflammations)
10/2010
1Acute Liver Failure (Fulminant Hepatic Failure)
10/2010
1Chemical and Drug Induced Liver Injury
10/2010
1Wounds and Injuries (Trauma)
09/2010

Drug/Important Bio-Agent (IBA)

2Transforming Growth Factor beta (TGF-beta)IBA
09/2011 - 01/2008
2human TGFB3 proteinIBA
09/2011 - 09/2010
2Pharmaceutical PreparationsIBA
10/2010 - 01/2008
1Biological ProductsIBA
04/2011
1Biomarkers (Surrogate Marker)IBA
10/2010
1CytokinesIBA
10/2010
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2010
1Prescription DrugsIBA
01/2008

Therapy/Procedure

1Therapeutics
09/2011